Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Acetic Acid → N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzenesulfonamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Acetic Acid | HCID 176 | — |
| 반응물 | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| 반응물 | 4-(4,5-Dichloro-2-methylpyrazol-3-yl)oxybenzenesulfonamide | HCID 1478245 | — |
| 반응물 | Diphenyl (5-bromo-1,3-thiazol-2-yl)imidodicarbonate | HCID 66858288 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzenesulfonamide | HCID 24780160 | — |
반응 단계
4-(4,5-dichloro-2-methyl-2H-pyrazol-3-yloxy)-benzenesulfonamide (77.3 mg, 0.24 mmol) and diphenyl (5-bromo-1,3-thiazol-2-yl)imidodicarbonate (100 mg, 0.24 mmol) were suspended in DMF (0.4 ml). A solution of DBU (0.04 ml, 0.26 mmol) in DMF (0.1 ml) was added dropwise and the clear mixture was shaken for 1.5 h at rt and kept overnight at 4° C. The mixture was acidified using acetic acid (0.2 ml) and diluted with water (0.2 ml) and purified directly using preparative RP(C18)chromatography: lyophilisate 9 mg, MS: m/e 523.8 (MH−).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07868030B2 |
| 출처 데이터셋 | uspto-grants-2011_01 |
| ORD ID | ord-b834cd58a75a4f18997d8625d3fa8c17 |
| 출처 메모 | uspto-grants-2011_01 |